FDA advisory panel scheduled to discuss Merck COVID-19 antiviral pill

The Food and Drug Administration (FDA) scheduled a meeting for late next month for its advisory panel to discuss Merck’s antiviral pill designed to treat mild-to-moderate COVID-19.The medication could be a game changer in the U.S.’s fight against…